PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2308

  1. 1,748 Posts.
    lightbulb Created with Sketch. 1895
    I can definitely understand that perspective. The strategic plan will always be priority number one.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.